跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 87 条关于
“leachable impurities”
全部
87
临床试验
31
药物
0
机构
0
资讯
56
去年
ICH Opens Public Consultation on Draft Q3E Guideline for Extractables and Leachables in Drug Products
9个月前
EpiVax and FDA Scientists Identify Immunogenicity Risks in Generic Teriparatide Impurities
9个月前
Piramal Pharma Solutions Achieves Full Regulatory Compliance for Nitrosamine Impurities
10个月前
FDA Issues Class II Recall for Over 580,000 Bottles of Prazosin Blood Pressure Medication Due to Cancer-Causing Impurities
去年
EMA Issues Updated Guidance on Non-Mutagenic Impurity Qualification to Reduce Animal Testing
5个月前
FDA Draft Guidance on Fermentation-Derived Antibiotics Sparks Industry Calls for Global Harmonization
3个月前
Waters Launches Industry-First Reversed-Phase Bioseparation Columns for Faster GLP-1 and LNP Analysis
去年
Aptar's N-Sorb Nitrosamine Mitigation Solution Accepted into FDA's Emerging Technology Program
去年
FDA Tightens Nitrosamine Testing Requirements with New Guidelines Taking Effect This August
上个月
Valisure Sues U.S. Pharmacopeia Over Claims Its Drug-Testing Methods Are 'Unvalidated'
第 1 页,共 6 页
上一页
下一页